| Relative Bioavailability of Sorafenib Tablet for Oral Suspension (NCT02538393) | Bayer | 2015-11-20 |
| Safety and Tolerability of BAY1862864 Injection in Subjects With Relapsed or Refractory CD22-positive Non-Hodgkin's Lymphoma (NCT02581878) | Bayer | 2015-11-20 |
| 3D Tissue Engineered Bone Equivalent for Treatment of Traumatic Bone Defects (NCT03103295) | A.A. Partners, LLC | 2015-11-20 |
| Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia (NCT02612545) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-20 |
| Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma (NCT02548468) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-11-20 |
| A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese Participants (NCT02541669) | Takeda | 2015-11-20 |
| Rivaroxaban for Treatment in Venous or Arterial Thrombosis in Neonates (NCT02564718) | Bayer | 2015-11-19 |
| Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study (NCT02528786) | Takeda | 2015-11-19 |
| Memory Modulation by Pain During Anesthesia (NCT02515890) | University of Pittsburgh | 2015-11-19 |
| A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation (NCT02586051) | Hoffmann-La Roche | 2015-11-19 |
| The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers (NCT04019652) | Daiichi Sankyo | 2015-11-19 |
| Evaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative Women (NCT02877979) | International Partnership for Microbicides, Inc. | 2015-11-18 |
| A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567. (NCT02512575) | AstraZeneca | 2015-11-18 |
| Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients (NCT02617550) | Bayer | 2015-11-18 |
| A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer (NCT02640365) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2015-11-18 |
| A Study of LY3113593 in Participants With Chronic Kidney Disease (NCT02604160) | Eli Lilly and Company | 2015-11-17 |
| A Study to Evaluate the Adherence of 2 Strengths of Newly Manufactured Samples and Aged Samples of a New Formulation (JNJ-35685-AAA-G016 and JNJ-35685-AAA-G021) of Fentanyl Transdermal System Compared With Duragesic Fentanyl Transdermal Patch in Healthy Participants (NCT02608320) | Janssen Research & Development, LLC | 2015-11-17 |
| A Study of MEDI7352 in Painful Osteoarthritis of the Knee (NCT02508155) | AstraZeneca | 2015-11-17 |
| Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT) (NCT02539654) | Alcon Research | 2015-11-17 |
| Positron Emission Tomography (PET) Study to Evaluate Biodistribution of [11C]-GSK2256098 in Healthy Subjects and Idiopathic Pulmonary Arterial Hypertension (PAH) Patients (NCT02551653) | GlaxoSmithKline | 2015-11-17 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants (NCT06193031) | Insmed Incorporated | 2015-11-17 |
| Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults (NCT02599896) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-16 |
| Study of Safety and Efficacy of BCL201 and Idelalisib in Patients With FL and MCL (NCT02603445) | Novartis Pharmaceuticals | 2015-11-16 |
| Pharmacokinetics of Entospletinib in Adults With Normal and Impaired Liver Function (NCT02521376) | Gilead Sciences | 2015-11-16 |
| First-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee Replacement (NCT02491281) | Novartis Pharmaceuticals | 2015-11-16 |
| A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects (NCT02601625) | AstraZeneca | 2015-11-16 |
| PF-06669571 In Subjects With Idiopathic Parkinson's Disease (NCT02565628) | Pfizer | 2015-11-16 |
| Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome (NCT02594215) | National Human Genome Research Institute (NHGRI) | 2015-11-16 |
| Intrathecal Autologous ADRC Treatment of Autoimmune Refractory Epilepsy (NCT03676569) | Mossakowski Medical Research Centre Polish Academy of Sciences | 2015-11-15 |
| Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults (NCT02601001) | Cytokinetics | 2015-11-13 |
| Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients With Locally Advanced Pancreatic Cancer (NCT02394535) | M.D. Anderson Cancer Center | 2015-11-12 |
| Dose-Escalation Study of ALXN1210 IV in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT02598583) | Alexion Pharmaceuticals, Inc. | 2015-11-12 |
| Study of MK-1248 With and Without Pembrolizumab (MK-3475) for Participants With Advanced Solid Tumors (MK-1248-001) (NCT02553499) | Merck Sharp & Dohme LLC | 2015-11-12 |
| Efficacy and Safety of Snail Slime and Natural Extracts for Healing in Diabetic Foot Ulcers (NCT03166423) | University of Chile | 2015-11-12 |
| Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC) (NCT02605486) | Memorial Sloan Kettering Cancer Center | 2015-11-11 |
| To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients (NCT02542605) | Amgen | 2015-11-11 |
| Safety and PK of MBX-400 (Cyclopropavir) in Normal Volunteers (NCT02454699) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-11-10 |
| Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer (NCT02588105) | AstraZeneca | 2015-11-10 |
| A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL) (NCT02594267) | Acrotech Biopharma Inc. | 2015-11-10 |
| A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects (NCT04029766) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2015-11-10 |
| Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL (NCT02557516) | Innate Pharma | 2015-11-09 |
| A Study in Adult Subjects With Select Advanced Solid Tumors (NCT02583165) | MedImmune LLC | 2015-11-09 |
| A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients (NCT02569372) | Green Cross Corporation | 2015-11-09 |
| A Study to Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease (NCT02580617) | Anterogen Co., Ltd. | 2015-11-09 |
| Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or Risperidone (NCT02634463) | Janssen Research & Development, LLC | 2015-11-09 |
| Study on Effects of BMS-955176 on the Pharmacokinetics of Probe Substrates (NCT02578277) | ViiV Healthcare | 2015-11-09 |
| A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) (NCT02554812) | Pfizer | 2015-11-09 |
| A Phase I Study of Osilodrostat (LCI699) in Healthy Volunteers and Subjects With Impaired Renal Function (NCT02399202) | Novartis Pharmaceuticals | 2015-11-06 |
| Study of Urelumab in Subjects With Advanced and/or Metastatic Malignant Tumors (NCT02534506) | Bristol-Myers Squibb | 2015-11-06 |
| Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma (NCT02584829) | Fred Hutchinson Cancer Center | 2015-11-06 |
| A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid Tumors (NCT02597036) | Eli Lilly and Company | 2015-11-06 |
| Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population (NCT03196661) | Hualan Biological Bacterin Co. Ltd. | 2015-11-06 |
| Bioequivalence Study of Nefopam Hydrochloride 30mg Tablets vs Acupan® 30mg Tablets in Healthy Subjects (NCT03311022) | Galen Limited | 2015-11-06 |
| THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROC (NCT02625207) | ViiV Healthcare | 2015-11-06 |
| A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer (NCT02561832) | AstraZeneca | 2015-11-06 |
| Iloprost in Preventing Lung Cancer in Former Smokers (NCT02237183) | National Cancer Institute (NCI) | 2015-11-05 |
| Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer (NCT02451553) | University of Washington | 2015-11-05 |
| A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma (NCT02609230) | Fox Chase Cancer Center | 2015-11-05 |
| PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors (NCT02584647) | Gulam Manji | 2015-11-04 |
| A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma (NCT02529852) | M.D. Anderson Cancer Center | 2015-11-04 |
| A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors (NCT02556463) | MedImmune LLC | 2015-11-04 |
| Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children (NCT02497716) | Bayer | 2015-11-04 |
| Phase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+ (NCT02593708) | Michelle Melisko | 2015-11-03 |
| Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT02420795) | M.D. Anderson Cancer Center | 2015-11-03 |
| Brentuximab Vedotin and Imatinib in Patients With Relapsed or Refractory ALK+ ALCL (NCT02462538) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2015-11-03 |
| Absolute Oral Bioavailability of Remimazolam (NCT04113564) | Paion UK Ltd. | 2015-11-03 |
| ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome (NCT02392572) | M.D. Anderson Cancer Center | 2015-11-03 |
| Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers (NCT02596711) | M.D. Anderson Cancer Center | 2015-11-02 |
| A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer (NCT02429843) | University of Alabama at Birmingham | 2015-11-02 |
| Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer (NCT02540356) | Baxalta now part of Shire | 2015-11-02 |
| Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers (NCT02732587) | Yale University | 2015-11-01 |
| A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants (NCT02595268) | Janssen Research & Development, LLC | 2015-11-01 |
| Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease (NCT02912169) | Ageless Regenerative Institute | 2015-11-01 |
| Therapeutic Treatment of Amyotrophic Lateral Sclerosis (NCT02881476) | University of Warmia and Mazury | 2015-11-01 |
| Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium (NCT02589366) | University of California, San Diego | 2015-11-01 |
| Effect of Gamma Tocopherol Enriched Supplementation on Response to Inhaled LPS (NCT02104505) | University of North Carolina, Chapel Hill | 2015-11-01 |
| Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients (NCT02598999) | Alaxia SAS | 2015-11-01 |
| Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers (NCT02616861) | Cyclerion Therapeutics | 2015-11-01 |
| Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants (NCT02578472) | Janssen-Cilag International NV | 2015-11-01 |
| A Brain Imaging Study With Positron Emission Tomography and the Radiotracer [11C]UCB-J to Estimate How Fast Brivaracetam and Levetiracetam Enter the Brain in Healthy Volunteers (NCT02602860) | UCB Pharma | 2015-11-01 |
| Safety Study of Pneumococcal 13-valent Conjugate Vaccine in Healthy People Aged 2 Months and Older (NCT02544698) | Beijing Chaoyang District Centre for Disease Control and Prevention | 2015-11-01 |
| Dermatopharmacokinetic Trial of LEO 80185 Gel (NCT02605057) | LEO Pharma | 2015-11-01 |
| Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults (NCT02609945) | Acorda Therapeutics | 2015-11-01 |
| Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers (NCT02616848) | Istituti Ospitalieri di Cremona | 2015-11-01 |
| Safety, Tolerability and Pharmacokinetic Study of MRG-201 in Healthy Volunteers (NCT02603224) | miRagen Therapeutics, Inc. | 2015-11-01 |
| Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration (NCT02613559) | Jiangsu T-Mab Biopharma Co.,Ltd | 2015-11-01 |
| Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis Pandemic (NCT02503839) | Anne Margarita Dyrhol Riise | 2015-11-01 |
| PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin (NCT02608242) | Yuhan Corporation | 2015-11-01 |
| tVNS for Depression (NCT02562703) | Santa Casa Medical School | 2015-11-01 |
| A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies (NCT02503033) | Hutchison Medipharma Limited | 2015-11-01 |
| Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant. (NCT02563366) | First Affiliated Hospital, Sun Yat-Sen University | 2015-11-01 |
| SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat (NCT02589158) | St Stephens Aids Trust | 2015-11-01 |
| An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome (NCT02562820) | The Cleveland Clinic | 2015-11-01 |
| Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) (NCT02558348) | Advenchen Laboratories, LLC | 2015-11-01 |
| Pembrolizumab in Combination With CRT for LA-SCCHN (NCT02586207) | Sanford Health | 2015-11-01 |
| Brief Bactericidal Activity of Anti-Tuberculosis Drugs (NCT02236078) | Centers for Disease Control and Prevention | 2015-11-01 |
| Effect of BM-MSCs on Chronic AMR After Kidney Transplantation (NCT02563340) | First Affiliated Hospital, Sun Yat-Sen University | 2015-11-01 |
| Melatonin and Sleep in Preventing Delirium in the Hospital (NCT02597231) | Scripps Health | 2015-11-01 |
| Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers (NCT02602509) | National University Hospital, Singapore | 2015-11-01 |
| Study Evaluating the Relevance and Reliability of Gastrointestinal Temperature Measurements From a New Device (E-celsius) (NCT02910479) | University Hospital, Caen | 2015-11-01 |